Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
+2.58M
-
Total reported value, excl. options
-
$765M
-
Value change
-
+$15.3M
-
Put/Call ratio
-
0.92
-
Number of buys
-
53
-
Number of sells
-
-32
-
Price
-
$6.00
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q3 2022
128 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
of 266M outstanding shares and own 47.84% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (34.2M shares), BAILLIE GIFFORD & CO (11M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), FMR LLC (9.21M shares), VANGUARD GROUP INC (8.84M shares), BlackRock Inc. (6.96M shares), STATE STREET CORP (6.55M shares), Public Sector Pension Investment Board (6.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.64M shares), and Crestline Management, LP (3.37M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.